IP Library › Granted Patent US 9,012,152
Granted Patent B2
US 9,012,152 · App. 12/522,545 · Granted Apr 21, 2015

Anti-bacterial peptides and methods of treating diseases using same

Inventors: Hanna Engelberg-Kulka (Jerusalem, IL); Ilana Kolodkin-Gal (Jerusalem, IL)
Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem
C07K14/245
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,012,152
App. No.
12/522,545
Granted
Apr 21, 2015
Kind
B2
Abstract

Isolated peptides comprising no more than ten amino acids and having anti-bacterial properties are disclosed. In one embodiment the peptides have a consensus amino acid sequence X 1 X 2 X 3 X 4 X 5 , wherein X 1 and X 5 comprise polar amino acids. In another embodiment, the peptides have a consensus amino acid sequence X 1 X 2 X 3 X 4 X 5 , wherein X 2 and X 4 are asparagine (N) residues and X 3 is tryptophan (W). Compositions comprising same are also disclosed and uses thereof.

Claims (4)

1. A method of killing bacteria which comprise the mazEF toxin-antitoxin module and which are in logarithmic growth, the method comprising contacting the bacteria with an effective amount of an isolated pentapeptide, comprising a consensus amino acid sequence X 1 X 2 X 3 X 4 X 5 , wherein both X 1 and X 5 comprise an amino acid independently selected from the group consisting of an asparagine residue and a glutamine residue wherein X 3 is a tryptophan residue and wherein X 2 and X 4 are each independently selected from the group consisting of an asparagine residue and a glycine residue, thereby killing bacteria.

2. The method of claim 1 , having an amino acid sequence as set forth in SEQ ID NO: 1.

3. The method of claim 1 , wherein the bacteria is of the genus Bacillus or Escherichia.

4. The method of claim 1 , wherein the bacteria are additionally contacted with at least one agent capable of reducing a level of MazE selected from the group consisting of an antibiotic, a DNA damaging agent and a serine analogue.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2009
From: ENGELBERG-KULKA, HANNA; KOLODKIN-GAL, ILANA
To: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM
Reel/Frame 023323/0032 →
Continuity (2)
Provisional Application 60879343 · Jan 9, 2007
Related Publication 20100104607A1 · Apr 29, 2010